5. JOZIASSE D H, ORIOL R. Xenotransplantation:the importance of the Galα1, 3Gal epitope in hyperacute vascular rejection[J]. Biochim Biophys Acta, 1999, 1455(2-3):403-418.
[2]
6. COLLINS B H, COTTERELL A H, MCCURRY K R, et al. Cardiac xenografts between primate species provide evidence for the importance of the alpha-galactosyl determinant in hyperacute rejection[J]. J Immunol, 1995, 154(10):5500-5510.
[3]
7. GALILI U, SHOHET S B, KOBRIN E, et al. Man, apes, and Old World monkeys differ from other mammals in the expression of alpha-galactosyl epitopes on nucleated cells[J]. J Biol Chem, 1988, 263(33):17755-17762.
[4]
8. JOZIASSE D H, SHAPER N L, KIM D, et al. Murine alpha 1, 3-galactosyltransferase. A single gene locus specifies four isoforms of the enzyme by alternative splicing[J]. J Biol Chem, 1992, 267(8):5534-5541.
[5]
9. NASO F, GANDAGLIA A, IOP L, et al. Alpha-Gal detectors in xenotransplantation research:a word of caution[J]. Xenotransplantation, 2012, 19(4):215-220.
[6]
10. GALILI U. The alpha-gal epitope and the anti-Gal antibody in xenotransplantation and in cancer immunotherapy[J]. Immunol Cell Biol, 2005, 83(6):674-686.
[7]
11. RIEBEN R, BOVIN N V, KORCHAGINA E Y, et al. Xenotransplantation:in vitro analysis of synthetic alpha-galactosyl inhibitors of human anti-Gal alpha 1→3Gal IgM and IgG antibodies[J]. Glycobiology, 2000, 10(2):141-148.
[8]
12. ECKHARDTA E, GOLDSTEIN I J. Isolation and characterization of a family ofα-galactosyl containing glycoproteins from Ebrlich-ascites tumor cells[J]. Biochemistry, 1983, 22(23):5290-5297.
[9]
13. MCKENZIE I F C, XING P X, VAUGHAN H A, et al. Distribution of the major xenoantigen (gal(α1-3)gal) for pig to human xenografts[J]. Transplant Immunology, 1994, 2(2):81-86.
15. GALILI U, LATEMPLE D C, RADIC M Z. A sensitive assay for measuring alpha-gal epitope expression on cells by a monoclonal anti-Gal antibody[J]. Transplantation, 1998, 65(8):1129-1132.
[12]
16. NASO F, GANDAGLIA A, LOP L, et al. First quantitative assay of alpha-Gal in soft tissues:presence and distribution of the epitope before and after cell removal from xenogeneic heart valves[J]. Acta Biomater, 2011, 7(4):1728-1734.
[13]
17. NASO F, GANDAGLIA A, BOTTIO T, et al. First quantification of alpha-Gal epitope in current glutaraldehyde-fixed heart valve bioprostheses[J]. Xenotransplantation, 2013, 20(4):252-261.
[14]
18. TANEMURA M, MARUYAMA S, GALILI U. Differential expression ofα-Gal epitopes (Galalpha1-3Galbeta1-4GlcNAc-R) on pig and mouse organs[J]. Transplantation, 2000, 69(1):187-190.
[15]
19. B？ER U, LOHRENZ A, KLINGENBERG M, et al. The effect of detergent-based decellularization procedures on cellular proteins and immunogenicity in equine carotid artery grafts[J]. Biomaterials, 2011, 32(36):9730-9737.
[16]
1. ？BADYLAK S F, GILBERT T W. Immune response to biologic scaffold materials[J]. Semin Immunol, 2008, 20(2):109-116.
[17]
2. BADYLAK S F. Xenogeneic extracellular matrix as a scaffold for tissue Reconstruction[J]. Transpl Immunol, 2004, 12(3/4):367-377.
[18]
3. ALLMAN A J, MCPHERSON T B, BADYLAK S F, et al. Xenogeneic extracellular matrix grafts elicit a TH2-restricted immune response[J]. Transplantation, 2001, 71(11):1631-1640.
[19]
4. SANDRIN M S, MCKENZIE I F. Gal alpha (1, 3)Gal, the major xenoantigen(s) recognised in pigs by human natural antibodies[J]. Immunol Rev, 1994, 141(10):169-190.
